These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 31304021)
1. Association between medicine Price declaration by pharmaceutical industries and retail prices in Malaysia's private healthcare sector. Ahmad NS; Hatah E; Makmor-Bakry M J Pharm Policy Pract; 2019; 12():15. PubMed ID: 31304021 [TBL] [Abstract][Full Text] [Related]
2. Multi stakeholders of health and industries perspectives on medicine price transparency initiative in private health care settings in Malaysia. Sufiza Ahmad N; Makmor-Bakry M; Hatah E Saudi Pharm J; 2020 Jul; 28(7):850-858. PubMed ID: 32647487 [TBL] [Abstract][Full Text] [Related]
3. Consumers' Knowledge, Attitudes, and Practices Toward Medicine Price Transparency at Private Healthcare Setting in Malaysia. Ahmad NS; Hatah E; Jalil MR; Makmor-Bakry M Front Public Health; 2021; 9():589734. PubMed ID: 34504820 [No Abstract] [Full Text] [Related]
4. How well does Malaysia achieve value for money in public sector purchasing of medicines? Evidence from medicines procurement prices from 2010 to 2014. Hamzah NM; Perera PN; Rannan-Eliya RP BMC Health Serv Res; 2020 Jun; 20(1):509. PubMed ID: 32503539 [TBL] [Abstract][Full Text] [Related]
5. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia. Babar ZU; Ibrahim MI; Singh H; Bukahri NI; Creese A PLoS Med; 2007 Mar; 4(3):e82. PubMed ID: 17388660 [TBL] [Abstract][Full Text] [Related]
6. Affordability of essential medicine prices in Malaysia's private health sector. Ahmad NS; Islahudin F Patient Prefer Adherence; 2018; 12():1231-1237. PubMed ID: 30038489 [TBL] [Abstract][Full Text] [Related]
7. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India. Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441 [TBL] [Abstract][Full Text] [Related]
8. Access and Affordability of Medicines in Malaysia: Need for a National Pricing Policy. Wong SL; Ibrahim S; Abdul Kadir N; Mohd Salleh S Appl Health Econ Health Policy; 2019 Oct; 17(5):641-654. PubMed ID: 31093937 [TBL] [Abstract][Full Text] [Related]
9. Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China. Yang H; Dib HH; Zhu M; Qi G; Zhang X Health Policy Plan; 2010 May; 25(3):219-29. PubMed ID: 19955093 [TBL] [Abstract][Full Text] [Related]
10. Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology. Sisay M; Amare F; Hagos B; Edessa D J Pharm Policy Pract; 2021 Jul; 14(1):57. PubMed ID: 34225781 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Cardiovascular Medicines Prices in Four European Countries. Mitkova Z; Vasileva M; Savova A; Manova M; Terezova S; Petrova G Front Public Health; 2020; 8():433. PubMed ID: 32974262 [TBL] [Abstract][Full Text] [Related]
12. Retail pharmacy prescription medicines' availability, prices and affordability in Eswatini. Shambira G; Suleman F Afr J Prim Health Care Fam Med; 2021 Sep; 13(1):e1-e11. PubMed ID: 34636605 [TBL] [Abstract][Full Text] [Related]
13. Prices and mark-ups on antimalarials: evidence from nationally representative studies in six malaria-endemic countries. Palafox B; Patouillard E; Tougher S; Goodman C; Hanson K; Kleinschmidt I; Torres Rueda S; Kiefer S; O'Connell K; Zinsou C; Phok S; Akulayi L; Arogundade E; Buyungo P; Mpasela F; Poyer S; Chavasse D Health Policy Plan; 2016 Mar; 31(2):148-60. PubMed ID: 25944705 [TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies. Acosta A; Ciapponi A; Aaserud M; Vietto V; Austvoll-Dahlgren A; Kösters JP; Vacca C; Machado M; Diaz Ayala DH; Oxman AD Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005979. PubMed ID: 25318966 [TBL] [Abstract][Full Text] [Related]
15. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Cameron A; Ewen M; Ross-Degnan D; Ball D; Laing R Lancet; 2009 Jan; 373(9659):240-9. PubMed ID: 19042012 [TBL] [Abstract][Full Text] [Related]
16. Medicine Prices, Availability, and Affordability in Private Health Facilities in Low-Income Settlements in Nairobi County, Kenya. Ongarora D; Karumbi J; Minnaard W; Abuga K; Okungu V; Kibwage I Pharmacy (Basel); 2019 Apr; 7(2):. PubMed ID: 31022841 [TBL] [Abstract][Full Text] [Related]
17. Evaluating access to essential medicines for treating childhood cancers: a medicines availability, price and affordability study in New Delhi, India. Faruqui N; Martiniuk A; Sharma A; Sharma C; Rathore B; Arora RS; Joshi R BMJ Glob Health; 2019; 4(2):e001379. PubMed ID: 31139456 [TBL] [Abstract][Full Text] [Related]
18. Medicine prices, availability and affordability in Sri Lanka. Senarathna SM; Mannapperuma U; Fernandopulle BM Indian J Pharmacol; 2011 Feb; 43(1):60-3. PubMed ID: 21455424 [TBL] [Abstract][Full Text] [Related]
19. Indication-wide drug pricing: Insights from the pharma market. Siegmeier F; Büssgen M J Pharm Policy Pract; 2022 Aug; 15(1):53. PubMed ID: 36038951 [TBL] [Abstract][Full Text] [Related]
20. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China. Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]